News

Filter

161 to 165 of 165 results

OXiGENE to acquire VaxGen in stock-for-stock merger worth around $22 million

16-10-2009

OXiGENE and fellow drug developer VaxGen have entered into a definitive merger agreement following which…

BiotechnologyMergers & AcquisitionsNorth AmericaOncologyOphthalmicsPharmaceutical

Phyton Biotech acquires assets of Natural Pharmaceuticals

13-10-2009

USA-based Phyton Biotech, an affiliate of Phyton Inc, has purchased the assets of Natural Pharmaceuticals,…

BiotechnologyGenericsMergers & AcquisitionsNorth AmericaOncologyPaclitaxelPharmaceuticalTaxol

Onyx to buy Proteolix for as much as $850 million to get blood cancer drug

12-10-2009

California, USA-based Proteolix has agreed to a takeover bid from Onyx Pharmaceuticals, valuing the firm…

AspirinBayerBayerBiotechnologybortezomibMergers & AcquisitionsNexavarNorth AmericaOncologyPharmaceuticalSorafenibVelcade

Ignyta in-licenses two tyrosine kinase inhibitors

US oncology focused biotech firm Ignyta has entered entry into a license agreement with Nerviano Medical…

BiotechnologyIgnytaLicensingMergers & AcquisitionsNerviano Medical SciencesOncologyRXDX-102

161 to 165 of 165 results

COMPANY SPOTLIGHT

Menarini

Back to top